Insulin aspart, recombinant Subcutaneous and Valproate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Valproate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproic acid, Valproic Acid and Derivatives
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Valproate Injection
- Insulin aspart, recombinant Subcutaneous-Valproate sodium Intravenous
- Insulin aspart, recombinant Subcutaneous-Valproic acid
- Insulin aspart, recombinant Subcutaneous-Valproic Acid and Derivatives
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Capsules
- Insulin aspart, recombinant Subcutaneous-Valproic Acid Liquid
- Valproate-Insulin degludec
- Valproate-Insulin Degludec (U-100) Prefilled Pens
- Valproate-Insulin Degludec (U-100) Vials
- Valproate-Insulin Degludec (U-200) Prefilled Pens
- Valproate-Insulin degludec and liraglutide
- Valproate-Insulin degludec and liraglutide Subcutaneous